Prolactogenic effects of risperidone in male patients - A preliminary study

Acta Psychiatrica Scandinavica

Volumn 98, Issue 1, 1998, Pages 81-83

  Shiwach, R S ^a   Carmody, T J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Dopamine; Prolactin; Risperidone; Testosterone

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; PROLACTIN; RISPERIDONE; TESTOSTERONE; THIORIDAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GYNECOMASTIA; HUMAN; HYPERPROLACTINEMIA; IMPOTENCE; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PROLACTIN RELEASE; SEXUAL DYSFUNCTION;

EID: 0031840210     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb10046.x     Document Type: Article

References (14)

1. GREEN AI, BROWN WA. Prolactin and neuroleptic drugs. Endocrinol Metab Clin North Am 1988: 17: 213-223.
2. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extra-pyramidal side-effects. Arch Gen Psychiatry 1992: 49: 538-544.
3. MELTZER HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 1989: 99: S18-S27.
4. MEGENS AAHP, AWOUTERS FHL, SCHOTTE TF et al. Survey on the pharmacodynamics of the new antipsychotic risperidone. Psychopharmacology 1994: 114: 9-23.
5. HUANG M, VAN PEER A, WOESTENBORGHS R et al. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. Clinical Pharmacol Ther 1993: 54: 257-268.
6. LANGER G, SACHER EJ, HALPERN FS, GRUEN PH, SOLOMON M. The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neuroendocrine studies in normal men. J Clin Endocrinol Metab 1977: 45: 996-1002.
7. DICKSON RA, DALBY JT, WILLIAMS R, EDWARDS AL. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia. Am J Psychiatry 1995: 152: 1102-1103.
8. HYMAN SE, ARANA GW, ROSENBAUM JF. Antipsychotic drugs. In: Handbook of psychiatric drug therapy, 3rd edn. New York: Little, Brown and Co., 1991: 8.
9. COHEN J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1989.
10. CHOUINARD G, JONES B, REMINGTON G et al. A Canadian muticenter placebo-controlled study of fixed dose of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacology 1993: 13: 25-40.
11. 2 receptor binding in risperidone-treated schizophrenic patients. J Clin Psychopharmacology 1995: 15 (Suppl. 1): 19S-23S.
12. COSTALL B, FORTUNE D, NAYLOR R, MARSDEN C, PYCOCK C. Serotonergic involvement with neuroleptic catalepsy. Neuropharmacology 1975: 14: 859-868.
13. MOLITCH ME. Pathological hyperprolactinemia. Endocrinol Metab Clin North Am 1992: 21: 877-900.
14. HOROWITZ JD, GOBLE AJ. Drugs and impaired male sexual function. Drugs 1979: 18: 206-217.